Five Prime Therapeutics Stock Price (NASDAQ:FPRX)

Add to My Stocks
$34.42 $0.36 (1.06%) FPRX stock closing price Apr 25, 2017 (Closing)
Five Prime Therapeutics
25 APR 2017
amigobulls logo
FPRX hand_up
FPRX vs S&P 500
Closing Price: Apr 25, 2017
$34.42 ( 1.06%)
S&P 500
2388.6 ( 0.61%)
52 Week Price Range
1 Year Return: -26.67%
Q4 Growth*
Profitable ?
net image
2016 Q4 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Five Prime Therapeutics Snapshot Video

12 5 2

FPRX Stock Details

Prev Close* : $34.06
Market Cap:
Day Low: $34.15
52 Week Low: $31.79
Open: $34.35
Volume: 453050
Day High: $35.13
52 Week High: $60.98

Latest Stock Market News

Latest Articles

Five Prime Therapeutics News - From Partners

FPRX Stockcharts

View FPRX PE ratio, PS ratio stocks charts and compare with peers.
FPRX Chart
Note: Compare Five Prime Therapeutics stock price history with the index and industry peers.

Five Prime Therapeutics Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Five Prime Therapeutics Financial Ratios

Asset Turnover
Receivables Turnover

FPRX Industry Peers

Company Price Change (%)
Idenix Pharma (IDIX)24.50.05 (0.2%)
Momenta Pharma (MNTA)13.850.5 (3.75%)
Bristol-myers Squibb (BMY)53.940.39 (0.73%)
Bluebird Bio (BLUE)87.752.1 (2.45%)
Pfizer (PFE)33.760.02 (0.06%)
Glaxosmithkline (GSK)41.480.36 (0.88%)
Eli Lilly (LLY)81.22.22 (2.66%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Epizyme (EPZM)17.452.55 (17.11%)
Sangamo BioSciences (SGMO)4.750.45 (10.47%)
Fortress Biotech (FBIO)3.570.29 (8.84%)
Idera Pharma (IDRA)2.4350.19 (8.44%)
Achillion Pharma (ACHN)3.480.27 (8.41%)
Revance (RVNC)22.451.55 (7.42%)
Immunomedics (IMMU)5.440.36 (7.08%)
Top gainers from Medical-Biomed-Genetics industry
* As of Apr 26, 2017
CompanyPriceChange (%)
AKARI THERAPTC (AKTX)15.252.24 (12.81%)
The Medicines Company (MDCO)49.112.34 (4.55%)
Kindred Biosciences (KIN)6.850.3 (4.2%)
ALBIREO PHARMA (ALBO)21.610.37 (1.68%)
Repligen (RGEN)34.630.48 (1.37%)
Cara Therapeutics (CARA)16.390.22 (1.32%)
NOVELION THERAP (NVLN)10.090.12 (1.18%)
Top losers from Medical-Biomed-Genetics industry
* As of Apr 26, 2017

Five Prime Therapeutics Inc Stock News - Partner Headlines

Value Investing in BioPharma   on Nov 18, 2015

Five Prime Therapeutics Financial Statements

income statement20162015201420132012
Net Sales Or Revenues30.69M379.8M19.23M13.79M9.98M
Net Income-65.69M249.64M-37.42M-28.87M-27.59M
Total Operating Expense129.9M92.82M56.8M43.2M37.77M
view Five Prime Therapeutics Inc income statement
balance sheet20162015201420132012
Total Assets448.28M548.28M155.63M81.79M44.09M
Total Liabilities56.7M115.07M70.42M23.76M23.68M
Shareholders Equity391.57M433.2M85.2M58.02M20.4M
view Five Prime Therapeutics Inc balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-71.07M36.22M46.18M-0.23M5.42M
Net Cash From (Used By) Operating Activities-79.75M289.09M15.26M-25.33M-18.39M
Increase (Decrease) In Prop Plant And Equipment-2.96M-2.42M-1.64M-0.8M-0.73M
view Five Prime Therapeutics Inc cashflow statement

Five Prime Therapeutics Stock Message Board

Five Prime Therapeutics stock price ended the last trading day at 34.42. Looking at Five Prime Therapeutics market capitalization, which currently stands at 979.8M, we can say that FPRX stock is a Small cap stock. Five Prime Therapeutics valuation can be guaged using various valuation metrics like the price to earnings ratio.

Demand for a stock decides its stock market price. For example, if more investors want to buy FPRX stock than sell it, then Five Prime Therapeutics stock price goes up. Conversely, if more investors wanted to sell FPRX stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume number in Five Prime Therapeutics stock quote data shows the number of shares traded. For Ex: 453050 Five Prime Therapeutics shares were traded as of last trading day, as seen from Five Prime Therapeutics stock chart. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Five Prime Therapeutics stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.